INS and metabolic dysfunction-associated steatohepatitis: Previous studies have reported that inhibition of ceramide synthesis could ameliorate NASH in rodent models through improving oxygen consumption, insulin resistance, lipoprotein metabolism and lipotoxicity [8–12].